Information platform for Japanese Medicines

Timolol XE Ophthalmic Solution 0.25% "TS"

Tags
Different Standards/Packaging Product
Log in or Sign up required.
Detailed information
Branded Name
Timolol XE Ophthalmic Solution 0.25% "TS"
Generic Name
Timolol Maleate
Heat Number / Carved Seal
N/A
Form / Color
- / -
Ministry of Health and Welfare Code
1319702Q3045
YJ Code
1319702Q3045
Manufacturer
Teika Pharmaceutical Co., Ltd.
MA holder
Teika Pharmaceutical Co., Ltd.
Restriction Information
-
Storage Condition
-
Cautions for Storage
-
Brand / Authorized Generic / Generic
Generic
Biological Origin / Biosimilar
No
Strength
0.25 %
Prescription Drug
No
Followed by Generic
not available
Effective date
000 00, 0000
Lot No.
00000000
Lead time
X days
Created at
Updated at
Log in or Sign up required.
Branded Name
Timolol XE Ophthalmic Solution 0.25% "TS"
Generic Name
Timolol Maleate
Heat Number / Carved Seal
N/A
Form / Color
- / -
Ministry of Health and Welfare Code
1319702Q3045
YJ Code
1319702Q3045
Manufacturer
Teika Pharmaceutical Co., Ltd.
MA holder
Teika Pharmaceutical Co., Ltd.
Restriction Information
-
Storage Condition
-
Cautions for Storage
-
Brand / Authorized Generic / Generic
Generic
Biological Origin / Biosimilar
No
Strength
0.25 %
Prescription Drug
No
Followed by Generic
not available
Effective date
000 00, 0000
Lot No.
00000000
Lead time
X days
Created at
Updated at
Log in or Sign up required.

Japanese notation

Product Name
チモロールXE点眼液0.25%「TS」
Name of Manufacturer
テイカ製薬
Name of MA Holder
テイカ製薬
Form / Color
液 / 無~微黄澄明

Alternative pharmaceuticals

*About alternative pharmaceuticals...This information is based on the active ingredients, dosage form, and specifications/units. It does not necessarily mean that the product is currently available.

No alternative pharmaceuticals found.
the English trade name

This website is available exclusively to healthcare professionals outside of Japan.

Registration and use by the general public are not permitted. Upon member registration, we will verify your credentials related to pharmaceutical transactions.

Are you a healthcare professional outside of Japan?